1P-32 PDF
代謝阻害剤で処理した動物培養細胞の13C代謝フラックス解析
Metabolic flux shifts in the metabolic inhibitor treated MCF-7 cells (human breast cancer) were investigated by the 13C metabolic flux analysis (13C MFA). Metabolic flux distributions estimated by 13C MFA suggested that a treatment of rotenone, a potent inhibitor of complex I, activated the reductive glutamine metabolism.